G Medical Innovations Holdings Ltd · OTC:GMVDF
G Medical Innovations — IPO Roadshow (June 2021)
26 slides from G Medical Innovations's IPO roadshow presentation, Jun 11, 2021
Slide 1: Our Mobile Devices and Data Monitoring Reduce Healthcare Costs and Improve Quality of Care
Our Mobile Devices and Data Monitoring Reduce Healthcare Costs and Improve Quality of Care MEDICAL JUNE 2021 INVESTOR PRESENTATION Issuer Free Writing Prospectus Dated June 11, 2021 Filed Pursuant to Rule 433 Relating To Preliminary Prospectus Dated June 8, 2021 Registration Statement No. 333 - 2538
Slide 2: Forward-Looking Statements
This document contains forward - looking statements . In addition, from time to time, we or our representatives may make forward - looking statements orally or in writing . We base these forward - looking statements on our expectations and projections about future events, which we derive from the in
Slide 3: Free Writing Prospectus
G Medical Innovations 3 This presentation highlights basic information about us and the proposed offering . Because it is a summary, it does not contain all the information that you should consider before investing . We have filed a registration statement (including a preliminary prospectus) with th
Slide 4: The Offering
THE OFFERING G Medical Innovations 4 ISSUER G MEDICAL INNOVATIONS HOLDINGS LTD. Proposed Maximum Aggregate Offering $17.5 M Price Range $5.00 - $7.00 Proposed Symbol Ordinary Shares: GMVD, Warrants: GMVDW Units Offered 2,500,000 Units (each consisting of one Ordinary Share and one Warrant to purchas
Slide 5: Investment Highlights
INVESTMENT HIGHLIGHTS G Medical Innovations 5 ▪ Founded in 2014, launched revenue - generating products and services in 2018 ▪ Led by individuals with more than 30 years of combined experience developing mobile embedded medical sensors and over 48 medical devices approved by the FDA ▪ Growth has bee
Slide 6: The Problem: Rising Complexity and Costs
6 G Medical Innovations ▪ The routine collection of diagnostic data incur high costs for providers and the patients Hard Costs Soft Costs • Purchase and maintenance of multiple devices • Patients’ time, effort – missed work for office visits • Doctors’ costs for visits and consultation • Doctors’ in
Slide 7: Mobile Remote Monitoring Improves Quality of Care
MOBILE REMOTE MONITORING MONITORING IMPROVES QUALITY OF CARE G Medical Innovations 7 Cardiac Diagnostic Contentious Monitoring Chronic Remote Patient Monitoring Data collection Telehealth cycle
Slide 8: Cardiac Data and Telemetry: Continuous Recording and Monitoring
▪ Two models continuously monitor cardiac results up to 14 or 30 days with an ‘extended Holter - type’ device for use in hospital or at home ▪ Each patient activation generates revenue with CPT - coded insurance reimbursement ▪ $300/patient for up to 14 days of monitoring or ▪ $750/patient for up to
Slide 9: Remote, User-Controlled On Demand Data and Monitoring
▪ US FDA - approved device produces diagnostic data with Electronic Medical Records (EMR) functionality ▪ Doctor - prescribed device and services tests, collects, stores, transmits and displays patient results accessed online or on Apple or Android app ▪ Remote, user - controlled as a stand - alone
Slide 10: Device and Monitoring for OTC Consumers
▪ FDA - approved and over - the - counter use by consumers to collect and store their own health diagnostic data ▪ Health - conscious individuals take an active role in their preventive health ▪ User - generated data retained in personal profiles in - app and online ▪ Subscription - based clinical m
Slide 11: Business Model
11 G Medical Innovations BUSINESS MODEL REVENUE GENERATOR PRIZ M A Prizma & Accessories Sales of Products Services Fee Income Cloud \ Portal Call Center Channe l s B2 B B2C • Healthcare Providers • Insurance Companies • Distributors • Online Store • Market Places • Patch unit • D isposables Sales of
Slide 12: Monitoring Services
Medicare - Certified, Independent Diagnostic Testing Facilities (IDTF) ▪ Two wholly – owned HIPAA compliant US patient monitoring call centers ▪ Monitoring service model generates recurring revenue ▪ Irregular data flagged for proactive clinical or medical engagement ▪ Online, mobile app and call ce
Slide 13: Approved by 150+ Healthcare Insurers
APPROVED BY 150+ HEALTHCARE INSURERS G Medical Innovations 13 SOURCE: Selected Customers from G Medical Customer List, 2021 USED BY 150+ DOCTORS, HOSPITALS AND CLINICS SOURCE: Selected Customers from G Medical Customer List, 2021 All trademarks are the property of their respective owners.
Slide 14: Competitor Matrix and Growth Model
# of Devices Needed Remote Operation Data Sets Collected Data Collection by User – Remote Monitoring G Medical 1 Many Others Many One FDA Approved Remote Operation Add New Functions OTC, Diagnostics and Monitoring G Medical Activity Trackers GROWTH MODEL G Medical Innovations 14 COMPETITOR MATRIX Le
Slide 15: Management Team
MANAGEMENT TEAM Dr . Yacov Geva , Managing Director and CEO , Executive Director A well - known pioneer in the industry of Medical Devices and remote monitoring services, and co - founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd . ) . Successfully led LifeWatch to
Slide 16: Board of Directors
BOARD OF DIRECTORS Dr . Kenneth R . Melani Non - Executive Chairman, began his career in 1981 as a practicing physician growing his internal medicine practice into the largest multi - specialty physician practice in Western Pennsylvania . In the mid 1980 ’s he helped start a physician hospital organ
Slide 17: Financial Overview
G Medical Innovations 17 ▪ Currently, most of the business activity is in the USA ▪ Most of revenues are from services and CPT reimbursements from our medical call centers (IDTF) ▪ Those include revenues from our cardiac monitoring services as MCT, CEM, Extended Holters and Holters services ▪ Althou
Slide 18: Use of Proceeds
USE OF PROCEEDS G Medical Innovations 18 ▪ 17 University Hospitals (UH) Approves G Medical Devices and Monitoring for In - Patient and Out - Patient Care ▪ Guthy - Renker Engaged for PRIZMA G2 Marketing and Social Media Outreach Beginning Q4 2021 ▪ G Medical Launches New, PRIZMA G2 Online Sales Plat
Slide 19: Comps
COMPANY TICKER BUSINESS DESCRIPTION 2020 REVENUES MARKET CAP PRICE/ SALES RATIO Teladoc Health, Inc. Nasdaq : TDOC Virtual healthcare services $1,094 M $23,632 M 21.6x iRhythm Technologies, Inc. Nasdaq: IRTC Develops, produces, and distributes medical instruments, for palpitation, shortness of breat
Slide 20: Visit Us Online
Mobility in Healthcare © 2021 G Medical Innovations, Inc. All rights reserved. MEDICAL VISIT US ONLINE Kingswood Capital Markets Victor Halpert Bryan Kobel Managing Director Managing Director (917) 602 - 2965 (646) 286 - 1962 vhalpert@kingswoodcm.com bkobel@kingswoodcm.com
Slide 21: Appendix
APPENDIX G Medical Innovations 21
Slide 22: Customer Segments: U.S. Healthcare Providers and Patients
Devices are delivered to Jeff at home or hospital - administered For preventative, outpatient or in patient care Jeff’s doctor prescribes a G Medical device Continuous or On - demand diagnostic data transmitted to the cloud/web Clinical Monitoring for at - home at home patients and triage with a phy
Slide 23: Customer Segments: Individual U.S. OTC Consumers
Regularly Collected Health Data stored in the individual's cloud Healthy - Minded Individuals want to take a more proactive role in their health Monitoring Service Subscription engages a clinician to review and interpret data plus An Option To Schedule a telehealth Evaluation By a Doctor PRIZMA G2 U
Slide 24: Patent Status
PATENT STATUS G Medical Innovations 24 Filing Date Application No. Title Country Product Type of patent protection Application Expiry date 03/31/2016 15/026,258 Systems and methods for vital signs monitoring with ear piece United States VSMS Utility patent 03/30/2036 01/30/2018 201790000342 - 0 Jack
Slide 25: Web Portal for Patients and Physicians
WEB PORTAL FOR PATIENTS AND PHYSICIANS G Medical Innovations 25 Top Menu help and 3rd party systems like CRM, Call Center and Online Store Patients medical history with option to edit and view for comprehensive status Abnormal measurements indication based on flexible time filter Incoming calls and
Slide 26: Diagnostic Data Is Essential for Care
▪ Medical professionals require diagnostic data to evaluate patients before, during and after healthcare engagements – a standard data set is collected by devices at every healthcare interaction ▪ In 2019, there were ~147 M hospital visits and ~884 M doctor visits in the US (CDC Website, 2021), at e
G Medical Innovations Holdings — IPO Roadshow (June 2021) on 6ix